Literature DB >> 11882517

Pulsatile growth hormone secretion persists in genetic growth hormone-releasing hormone resistance.

Hiralal G Maheshwari1, Suzan S Pezzoli, Asad Rahim, Stephen M Shalet, Michael O Thorner, Gerhard Baumann.   

Abstract

Growth hormone (GH) secretion is regulated by GH-releasing hormone (GHRH), somatostatin, and possibly ghrelin, but uncertainty remains about the relative contributions of these hypophysiotropic factors to GH pulsatility. Patients with genetic GHRH receptor (GHRH-R) deficiency present an opportunity to examine GH secretory dynamics in the selective absence of GHRH input. We studied circadian GH profiles in four young men homozygous for a null mutation in the GHRH-R gene by use of an ultrasensitive GH assay. Residual GH secretion was pulsatile, with normal pulse frequency, but severely reduced amplitude (<1% normal) and greater than normal process disorder (as assessed by approximate entropy). Nocturnal GH secretion, both basal and pulsatile, was enhanced compared with daytime. We conclude that rhythmic GH secretion persists in an amplitude-miniaturized version in the absence of a GHRH-R signal. The nocturnal enhancement of GH secretion is likely mediated by decreased somatostatin tone. Pulsatility of residual GH secretion may be caused by oscillations in somatostatin and/or ghrelin; it may also reflect intrinsic oscillations in somatotropes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11882517     DOI: 10.1152/ajpendo.00537.2001

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  10 in total

1.  Ghrelin and Helicobacter pylori.

Authors:  C D R Murray; A V Emmanuel
Journal:  Gut       Date:  2004-02       Impact factor: 23.059

Review 2.  Growth hormone and IGF-1.

Authors:  Roberto Salvatori
Journal:  Rev Endocr Metab Disord       Date:  2004-03       Impact factor: 6.514

3.  GH response to hypoglycemia and clonidine in the GH-releasing hormone resistance syndrome.

Authors:  R Salvatori; M G Serpa; G Parmigiani; A V O Britto; J L M Oliveira; C R P Oliveira; C M Prado; C T Farias; J C Almeida; T A R Vicente; M H Aguiar-Oliveira
Journal:  J Endocrinol Invest       Date:  2006-10       Impact factor: 4.256

Review 4.  Growth Hormone Deficiency: Health and Longevity.

Authors:  Manuel H Aguiar-Oliveira; Andrzej Bartke
Journal:  Endocr Rev       Date:  2019-04-01       Impact factor: 19.871

Review 5.  The role of ghrelin in GH secretion and GH disorders.

Authors:  Ralf Nass; Bruce D Gaylinn; Michael O Thorner
Journal:  Mol Cell Endocrinol       Date:  2011-04-01       Impact factor: 4.102

Review 6.  The Complex World of Regulation of Pituitary Growth Hormone Secretion: The Role of Ghrelin, Klotho, and Nesfatins in It.

Authors:  Jesús Devesa
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-11       Impact factor: 5.555

7.  Evidence for acyl-ghrelin modulation of growth hormone release in the fed state.

Authors:  Ralf Nass; Leon S Farhy; Jianhua Liu; Catherine E Prudom; Michael L Johnson; Paula Veldhuis; Suzan S Pezzoli; Mary Clancy Oliveri; Bruce D Gaylinn; H Mario Geysen; Michael O Thorner
Journal:  J Clin Endocrinol Metab       Date:  2008-03-11       Impact factor: 5.958

8.  AutoDecon: a robust numerical method for the quantification of pulsatile events.

Authors:  Michael L Johnson; Lenore Pipes; Paula P Veldhuis; Leon S Farhy; Ralf Nass; Michael O Thorner; William S Evans
Journal:  Methods Enzymol       Date:  2009       Impact factor: 1.600

9.  Growth hormone response to growth hormone-releasing peptide-2 in growth hormone-deficient little mice.

Authors:  Cibele N Peroni; Cesar Y Hayashida; Nancy Nascimento; Viviane C Longuini; Rodrigo A Toledo; Paolo Bartolini; Cyril Y Bowers; Sergio P A Toledo
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365

10.  Response of multiple hormones to glucose and arginine challenge in T2DM after gastric bypass.

Authors:  Giovanni Fanni; Petros Katsogiannos; Bipasha Nandi Jui; Magnus Sundbom; Susanne Hetty; Maria J Pereira; Jan W Eriksson
Journal:  Endocr Connect       Date:  2022-07-25       Impact factor: 3.221

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.